Literature DB >> 16562134

Metabolism of 6-Mercaptopurine by Resistant Escherichia coli Cells.

J H Coggin1, M Loosemore, W R Martin.   

Abstract

Coggin, Joseph H. (University of Chicago, Chicago, Ill.), Muriel Loosemore, and William R. Martin. Metabolism of 6-mercaptopurine by resistant Escherichia coli cells. J. Bacteriol. 92:446-454. 1966.-6-Mercaptopurine (MP) utilization as a source of purine in MP-sensitive and -resistant cultures of Escherichia coli was investigated. The label of MP-8-C(14) appeared in adenine and guanine of ribonucleic acid and deoxyribonucleic acid in sensitive and resistant cultures. Studies using MP-S(35) further demonstrated that the MP moiety was degraded, as shown by a rapid decrease in radioactivity from cells upon exposure to MP for 20 min. Enzymatic analysis showed that MP was converted to 6-mercaptopurine ribonucleotide (MPRP) by extracts derived from both sensitive and resistant cells. Resistant cell preparations, however, degraded MPRP to inosine monophosphate (IMP) rapidly when compared with analogue degradation by sensitive cells. Inosineguanosine-5'-phosphate pyrophosphorylase from resistant cells did not catalyze the synthesis of IMP from hypoxanthine when the cells were cultured in the presence of MP, but these enzyme preparations actively converted guanine to guanosine monophosphate (GMP). Pyrophosphorylase derived from resistant cells cultured in medium without MP catalyzed the conversion of hypoxanthine to IMP and also guanine to GMP. These observations suggest that inosine-guanosine-5'-phosphate pyrophosphorylase is composed of two distinct enzymes. The mode of resistance to MP in E. coli is related to an enhancement of the enzymatic degradation of MPRP to the pivotal purine intermediate, IMP.

Entities:  

Year:  1966        PMID: 16562134      PMCID: PMC276262          DOI: 10.1128/jb.92.2.446-454.1966

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  17 in total

1.  Studies on drug resistance in mammalian cells. II. 6-Mercaptopurine resistance in mouse fibroblasts.

Authors:  S TOMIZAWA; L ARONOW
Journal:  J Pharmacol Exp Ther       Date:  1960-02       Impact factor: 4.030

2.  A mechanism of resistance to 8-azaguanine. I. Microbiological studies on the metabolism of purines and 8 azapurines.

Authors:  R W BROCKMAN; C SPARKS; D J HUTCHISON; H E SKIPPER
Journal:  Cancer Res       Date:  1959-02       Impact factor: 12.701

3.  Reaction of 6-mercaptopurine with inosine- and guanosine-5'-phosphate pyrophosphorylase purified from E. coli.

Authors:  C E CARTER
Journal:  Biochem Pharmacol       Date:  1959-08       Impact factor: 5.858

4.  Metabolism of uracil and 5-fluorouracil by drug-sensitive and by drug-resistant bacteria.

Authors:  R W BROCKMAN; J M DAVIS; P STUTTS
Journal:  Biochim Biophys Acta       Date:  1960-05-06

5.  Enzymic formation of 6-mercaptopurine tibo tide.

Authors:  L N LUKENS; K A HERRINGTON
Journal:  Biochim Biophys Acta       Date:  1957-05

6.  Enzymatic synthesis of 5'-phosphate nucleotides of purine analogues.

Authors:  J L WAY; R E PARKS
Journal:  J Biol Chem       Date:  1958-03       Impact factor: 5.157

7.  Metabolism of resistant mutants of Streptococcus faecalis. III. The action of 6-mercaptopurine.

Authors:  M E BALIS; V HYLIN; M K COULTAS; D J HUTCHINSON
Journal:  Cancer Res       Date:  1958-05       Impact factor: 12.701

8.  Metabolism of resistant mutants of Streptococcus faecalis. II. Incorporation of exogenous purines.

Authors:  M E BALIS; V HYLIN; M K COULTAS; D J HUTCHISON
Journal:  Cancer Res       Date:  1958-02       Impact factor: 12.701

9.  Differences between cancers in terms of evolution of drug resistance.

Authors:  L W LAW
Journal:  Cancer Res       Date:  1956-08       Impact factor: 12.701

10.  Chromatographic studies of purine metabolism. VI. Inhibition of inosine phosphorylase by 6-mercaptopurine.

Authors:  A J Tomisek; A P Hoskins; M R Reid
Journal:  Cancer Res       Date:  1965-12       Impact factor: 12.701

View more
  6 in total

1.  Incorporation of Exogenous Purines and Pyrimidines by Methanococcus voltae and Isolation of Analog-Resistant Mutants.

Authors:  T L Bowen; W B Whitman
Journal:  Appl Environ Microbiol       Date:  1987-08       Impact factor: 4.792

2.  Selection for purine regulatory mutants in an E. coli hypoxanthine phosphoribosyl transferase-guanine phosphoribosyl transferase double mutant.

Authors:  R A Levine; M W Taylor
Journal:  Mol Gen Genet       Date:  1981

3.  Genetic separation of hypoxanthine and guanine-xanthine phosphoribosyltransferase activities by deletion mutations in Salmonella typhimurium.

Authors:  J S Gots; C E Benson; S R Shumas
Journal:  J Bacteriol       Date:  1972-11       Impact factor: 3.490

4.  Use of Escherichia coli mutants to evaluate purines, purine nucleosides, and analogues.

Authors:  D L Hill; R F Pittillo
Journal:  Antimicrob Agents Chemother       Date:  1973-08       Impact factor: 5.191

5.  On the action of methotrexate and 6-mercaptopurine on M. avium subspecies paratuberculosis.

Authors:  Robert J Greenstein; Liya Su; Vahram Haroutunian; Azra Shahidi; Sheldon T Brown
Journal:  PLoS One       Date:  2007-01-24       Impact factor: 3.240

6.  Chemical-Chemical Combinations Map Uncharted Interactions in Escherichia coli under Nutrient Stress.

Authors:  Sara S El Zahed; Eric D Brown
Journal:  iScience       Date:  2018-03-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.